TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
GRAL

GRAIL, LLC

Healthcare · Diagnostics & Research

80.80$ +1.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GRAL
Line item 2018 2019 2020 2021 2022 2023 2024 2025
+280.2% +67.6% +34.9% +17.2%
-26.8% +50.1% +9.7% +7.9% +3.0%
-25.1% +15.5% +138.6% -28.4% +2.8% -4.8% -39.3%
+38.9% +36.0% +64.1% -3.6% +15.0% +6.8% -25.6%
-11.1% +23.8% +268.3% +357.1% -73.3% +48.7% -77.7%
-140.2% -53,060.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?